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Abstract: Quantitative susceptibility mapping (QSM) is a novel processing method for gradient-echo
magnetic resonance imaging (MRI). Higher magnetic susceptibility in cortical veins have been observed
on susceptibility maps in the ischemic hemisphere of stroke patients, indicating an increased oxygen
extraction fraction (OEF). Our goal was to investigate susceptibility in veins of stroke patients after
successful recanalization in order to analyze the value of QSM in predicting tissue prognosis and clinical
outcome. We analyzed MR images of 23 patients with stroke due to unilateral middle cerebral artery
(MCA)-M1/M2 occlusion acquired 24-72 h after successful thrombectomy. The susceptibilities of veins
were obtained from QSM and compared between the stroke territory, the ipsilateral non-ischemic MCA
territory and the contralateral MCA territory. As outcome variables, early infarct size and functional
disability (modified Rankin Scale, mRS) after 3-5 months was used. The median susceptibility value of
cortical veins in the ischemic core was 41% lower compared to the ipsilateral non-ischemic MCA territory
and 38% lower than on the contralateral MCA territory. Strikingly, in none of the patients prominent
vessels with high susceptibility signal were found after recanalization. Venous susceptibility values within
the infarct did not correlate with infarct volume or functional disability after 3-5 months. Low venous
susceptibility within the infarct core after successful recanalization of the occluded vessel likely indicates
poor oxygen extraction arising from tissue damage. We did not identify peri-infarct tissue with increased
susceptibility values as potential surrogate of former penumbral areas. We found no correlation of QSM
parameters with infarct size or outcome.
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Quantitative susceptibility mapping (QSM) is a novel processing method for gradient-echo magnetic 
resonance imaging (MRI). Higher magnetic susceptibility in cortical veins have been observed on 
susceptibility maps in the ischemic hemisphere of stroke patients, indicating an increased oxygen 
extraction fraction (OEF). Our goal was to investigate susceptibility in veins of stroke patients 
after successful recanalization in order to analyze the value of QSM in predicting tissue prognosis 
and clinical outcome. We analyzed MR images of 23 patients with stroke due to unilateral middle 
cerebral artery (MCA)-M1/M2 occlusion acquired 24–72 h after successful thrombectomy. The 
susceptibilities of veins were obtained from QSM and compared between the stroke territory, the 
ipsilateral non-ischemic MCA territory and the contralateral MCA territory. As outcome variables, 
early infarct size and functional disability (modified Rankin Scale, mRS) after 3–5 months was used. 
The median susceptibility value of cortical veins in the ischemic core was 41% lower compared to 
the ipsilateral non-ischemic MCA territory and 38% lower than on the contralateral MCA territory. 
Strikingly, in none of the patients prominent vessels with high susceptibility signal were found after 
recanalization. Venous susceptibility values within the infarct did not correlate with infarct volume 
or functional disability after 3–5 months. Low venous susceptibility within the infarct core after 
successful recanalization of the occluded vessel likely indicates poor oxygen extraction arising from 
tissue damage. We did not identify peri-infarct tissue with increased susceptibility values as potential 
surrogate of former penumbral areas. We found no correlation of QSM parameters with infarct size or 
outcome.
Magnetic susceptibility is a fundamental physical property of materials that describes their ability to become 
magnetized. It represents a unique contrast mechanism to image tissue in magnetic resonance imaging (MRI)1–3. 
Susceptibility-based tissue contrasts can be deduced by post-processing of the complex-valued signal derived 
from T2*-weighted gradient-echo  scans4–9. While the technique susceptibility weighted imaging (SWI) has 
already been established in neuroradiological diagnostics, its successor quantitative susceptibility mapping 
(QSM) is increasingly gaining consideration in clinical research. Both techniques reveal anatomic and physiologic 
information about the type of tissue and offer superb visualizations of the cerebral venous  vasculature1,10–12. As 
susceptibility reflects the magnetizability of a tissue, it is sensitive to local and global oxygenation. The oxygen 
extraction fraction (OEF) level in cerebral veins directly relates to the concentration of paramagnetic deoxygen-
ated hemoglobin molecules in the  vessels12–14. Thus, magnetic susceptibility based contrast have been used to 
describe oxygenation status in the  brain14,15.
QSM has been applied in the assessment of vessel function and oxygen metabolism in patients and animal 
models with acute ischemic  stroke16–19. In patients with acute stroke, prominent vessels with high magnetic sus-
ceptibility were observed with SWI and  QSM18,20–23. These have been referred to as asymmetrically prominent 
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cortical veins (APCVs) and were found within the infarcted perfused area, indicating tendency of clinical dete-
rioration in stroke  patients18. The appearance of prominent vessels on QSM has been associated with the ischemic 
penumbra (or “tissue at risk”) which is characterized by an increase in OEF (misery perfusion) and good tissue 
prognosis after  recanalization18–20. In penumbral areas, increased OEF likely leads to higher deoxyhemoglobin 
concentrations in cortical veins, which then increases magnetic  susceptibility19,22,24. Animal models of transient 
focal ischemia have shown that prominent vessels persist long after  recanalization5,8. However, susceptibility 
values in cortical veins have so far not been assessed in stroke patients after successfull recanalization.
The primary goal of this study was to extend previous preliminary findings with QSM to investigate the dif-
ferences in susceptibility values of cortical veins between the infarcted area, border and non-infarcted areas in 
ischemic stroke patients after successful recanalization. We hypothesized that QSM could provide a measure of 
tissue oxygen extraction and thus potentially aid in discriminating tissues with different  fate19–21. In addition, 
we correlated susceptibility values of cortical veins with functional disability after 3–5 months as well as infarct 
volume, an established predictive factor of clinical outcome in patients with middle cerebral artery (MCA) 
 occlusions25.
Materials and methods
Study design and cohort description. During the period of December 2016 until October 2018, we 
screened MRI and clinical data of patients with ischemic stroke due to MCA-M1 or MCA-M2 occlusion referred 
for thrombectomy at the Department of Neurology, University Hospital Zurich. Post-treatment MR images were 
acquired 24–72 h after successful recanalization. Of 263 patients receiving thrombectomy for acute ischemic 
stroke in 39 cases MCA-M1 or MCA-M2 occlusion was present and  T2*w raw data for QSM analysis could be 
extracted on site during official working times.
The study was approved by the local ethics committee (Kantonale Ethikkommission Zurich; KEK-ZH-Nr 
2014-0304). Informed consent was obtained from all participants as required by the ethics protocol. Only cases 
with successful recanalization verified by catheter angiography (defined as Thrombolysis in Cerebral Infarction 
(TICI) 2b or TICI 3  score26) were included in the study and if the recorded MRI data were of sufficient quality. 
To further evaluate recanalization, we analyzed flow in the MCA-M1 segment derived from routine transcranial 
duplex sonography (in cm/s) performed on day 0 to day 1 after thrombectomy.
Out of 39 patients eligible for further analysis, 34 agreed to take part in the data collection for this study. 
Six patients without or only partially successful recanalization according to the TICI reperfusion grade and five 
patients with technical issues (one with blurred images, one with missing MRI sequences essential to analysis, 
and three with massive hemorrhages compromising cortical vein identification) were excluded from further 
analysis, leading to 23 patients with successfully recanalized MCA-M1/M2 occlusion included in the current 
study. A flowchart illustrating patient selection is shown in Fig. 1.
Clinical variables including demographic data, medical history, associated risk factors and stroke etiology 
were gathered. In addition, information on treatment and outcome was collected, including information on 
intravenous thrombolysis, onset-to-needle time (ONT), NIH-Stroke Scale (NIHSS) on admission and after 24 h, 
and modified Rankin Scale (mRS) after 3–5 months. We determined infarct volume after recanalization from 
diffusion weighted imaging (DWI) which was performed between days 1 and 3 after stroke.
MRI acquisition and post-processing. All MR images were acquired on a 3 Tesla MRI Scanner (Skyra, 
release VD13, Siemens Healthcare, Erlangen, Germany). DWI (acquisition type 2D, read-out segmented echo 
planar imaging approach, field of view 220 × 220  [mm2], number of slices 38, voxel size 1.1 × 1.1 × 3.0  [mm3], 
slice gap 0.9 [mm], repetition time (TR) 7340 [ms], echo time (TE) 68 [ms], B-values 0 respectively 1000 [s/
mm2], acquisition time (TA) 4:33 [min:s]), T2*-weighted gradient echo imaging (T2*w) (acquisition type 3D 
FLASH, first-order flow compensation in all three spatial directions, field of view 220 × 193  [mm2], number of 
slices 88, voxel size 0.9 × 0.9 × 1.6  [mm3], TR 27 [ms], TE 20 [ms], band width 120 [Hz/px], TA 3:29 [min:s]), 
fluid-attenuated inversion recovery (FLAIR) (acquisition type 3D, field of view 240 × 233  [mm2], number of 
slices 176, voxel size 0.5 × 0.5 × 1.0  [mm3], TR 4700 [ms], TE 386 [ms], inversion time (TI) 1530 [ms], TA 5:59 
[min:s]), and T2-weighted imaging (T2w) (acquisition type 2D, turbo-spin echo approach (TSE), field of view 
220 × 220  [mm2], number of slices 44, voxel size 0.4 × 0.4 × 3.0  [mm3], slice gap 0.3 [mm], TR 8180 [ms], TE 100 
[ms], TA 3:26 [min:s]), sequences were acquired in transverse orientation.
Gradient-echo data were processed as outlined in detail below using in-house software that was written in 
Matlab (The Mathworks Inc., Natick, MA, USA) and utilized FSL’s brain extraction tool for brain  masking27. Mag-
nitude and phase images of the T2*w gradient-echo sequence were employed to compute susceptibility weighted 
images utilizing Laplacian-filtering as described  in28. Quantitative susceptibility maps were computed from the 
phase images of the SWI scan by applying Laplacian-based phase  unwrapping29 followed by “sophisticated har-
monic artifact reduction for phase data with variable spherical kernels” (V-SHARP)30 to eliminate background 
fields and by “homogeneity enabled dipole inversion” (HEIDI)31 to solve the ill-posed inverse problem between 
local magnetic field and magnetic susceptibility. Residual non-harmonic background field contributions, e.g., 
resulting from B1-related transceiver phase were implicitly suppressed by applying V-SHARP with high-pass 
filter regularization (cut-off frequency = 0.012  mm−1)32. Susceptibility maps were referenced to the mean cerebro-
spinal fluid (CSF) susceptibility. To measure CSF susceptibility, masks were drawn bilaterally in the center of the 
anterior horn of the lateral ventricles in three axial slices as described in Straub et al.33. Susceptibility values are 
given in parts-per-million (ppm). Finally, maximum-intensity projections of susceptibility maps were calculated 
across a slab 12.8 mm thick.
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MR image analysis. In all patients, the same six slices representative for the MCA territory were selected. 
MCA territories were anatomically defined as areas supplied by the middle cerebral artery. Massive hemor-
rhages compromising cortical vein detection (applicable to three patients) were identified and excluded from the 
analysis considering standard imaging approaches for hemorrhages (SWI and CT scans were checked for each 
patient). Images were then analyzed using the Image J (NIH)  software34. For each individual, a threshold was 
applied such that pixel above this threshold were considered to be veins without marking any background tissue. 
Thresholds were kept constant during analysis of each individual. Susceptibility values from QSM images within 
semi-automatically drawn masks of individual cortical veins that appeared prominent were analyzed, regardless 
of their site. An example is demonstrated in Fig. 2 showing the DWI, SWI and QSM as well as cortical veins on 3 
representative slices of the MCA territory. When cortical veins were not identifiable semi-automatically because 
of interference with background tissue, a manual selection was added. In that case, we inspected the suscepti-
bility maps and their maximum intensity projections (MIP) across 6 mm as well as the SWI image to identify 
cortical veins precisely. In addition, all semi-automatically drawn maps were visually compared to susceptibility 
maps, susceptibility weighted images and their MIPs to correct for contributions of uncompletely removed back-
ground fields originating from the sinus cavities and background tissue, which is shown in Fig. 3. Vein masks 
were drawn by two independent experts. Both examiners then agreed on what should be included into the vein 
mask. The interrater variability was analyzed utilizing Interclass Interrater Coefficient (ICC), which showed 
values between 0.94 and 0.98, indicating high interrater reliability (please see more detailed information in the 
supplementary material). Vein susceptibilities were calculated from the 10% highest signal within the vein mask 
to minimize partial volume effects; and values from both examiners were averaged. A distinction was made 
Figure 1.  Patient inclusion criteria flow chart. Out of 263 patients referred for thrombectomy between 
December 2016 and October 2018 in 39 cases with MCA-M1/M2 occlusion MRI raw data for QSM analysis 
could be retrieved on site and assessed for eligibility. Patients were excluded due to refusal of consent, 
unsuccessful recanalization or due to technical problems that occurred during image analysis/processing (e.g. 
blurred images, massive hemorrhages or missing MRI-sequences essential to analysis) leading to 23 patients 
with successfully recanalized MCA-M1/M2 occlusion included in the current study.
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between veins within the stroke core, the ipsilateral non-ischemic MCA territory and the contralateral MCA 
territory. The stroke core was identified as hyperintense tissue signal on DWI and delineated semiautomatically 
utilizing the ImageJ threshold tool for delineation and manual correction with a consistent threshold for each 
individual. Thresholds for stroke core delineation were divergent between individuals.
Statistical analyses. All statistical analyses were perfomed using the IBM SPSS Statistics software ver-
sion 25. Comparisons between groups were done using the non-parametric Kruskal–Wallis-test. For correlation 
analyses between susceptibility values, clinical parameters (NIHSS on admission and mRS after 3–5 months), 
severity of ADC decrease within the infarction and infarct volume, we calculated Pearson’s correlation coeffi-
cient. A p-value below 0.05 was considered as statistically significant.
Statement of ethics. The study was approved by the local ethics committee (Kantonale Ethikkomission 
Zurich; KEK-ZH-Nr 2014-0304). All procedures performed were in accordance with the ethical standards of 
the institutional and/or national research committee and with the 1964 Word Medical Association Declaration 
of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from all 
participants as required by the ethics protocol.
Figure 2.  MR images of a stroke patient aged 49 years with successfully recanalized MCA-M1 occlusion on 
the left hemisphere. The DWI (a) shows the hyperintense infarct area on the left hemisphere. The SWI (b) helps 
identifying the localization of vessels. The corresponding susceptibility map is depicted in (c). Veins with higher 
levels of paramagnetic deoxyhemoglobin content appear brighter (red arrows). Representative susceptibility 
images covering the MCA territory are shown in (d–f). Cortical veins are delineated in different colors 
depending on the territory. Within the stroke area (yellow line) defined by DWI cortical veins are delineated 
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Results
Patient cohort and clinical characteristics. During the period of December 2016 until October 2018, 
out of 263 patients with ischemic stroke referred for thrombectomy at the Department of Neurology, University 
Hospital Zurich, 23 patients with successfully recanalized MCA-M1/M2 occlusion were included in the study 
according to study plan.
Patients’ clinical characteristics are shown in Table 1. The median age of the patient population was 72 years. 
The most common risk factors were hypertension (57%) and atrial fibrillation (43%). Cardioembolic events were 
observed in more than 50% of the cases and therefore the most common cause of stroke in our patient popula-
tion. In eight patients (35%) the cause of stroke could not be determined. Duplex sonography flow values of the 
recanalized MCA-M1/M2 were derived from patient charts and are shown in Table 2. In two cases, results from 
duplex sonography were not available. Flow in the ipsilateral MCA-M1 was similar to the contralateral side, 
confirming successful recanalization.
Information on neurological deficit upon admission and 3–5 months after discharge from the hospital is 
shown in Table 2. The median NIHSS on admission was 13 (IQR 6, Minimum 3, Maximum 19) and was improved 
by a median of 4 points (IQR 9.5, Minimum − 9, Maximum 14) on day 1 while the median mRS 3–5 months 
after hospitalization was 2 (IQR 2.5, Minimum 0, Maximum 6). 18/23 (78%) patients received intravenous 
thrombolysis in addition to thrombectomy. The median onset-to-needle time for patients receiving intravenous 
thrombolysis was 150 min (IQR of 111, Minimum 40, Maximum 390).
Analysis of susceptibility values of cortical veins. Shown in Table 3, the median (IQR; Min–Max) 
infarct volume was 33.52  cm3 (71.5; 1.07–250.8). The median number of veins found within the stroke area was 
9 (21; 2–88).
In Fig. 4 and Table 3, the mean susceptibility values of cortical veins within the stroke core area, the ipsilateral 
non-ischemic MCA territory and the contralateral MCA territory of all stroke patients are shown. The median 
(IQR; Min–Max) susceptibility value of the cortical veins in the stroke areas was 0.050 ppm (0.02; 0.03–0.08). The 
median susceptibility value of the ipsilateral non-ischemic MCA territory was 0.085 ppm (0.04; 0.05–0.12) and 
of the contralateral MCA territory was 0.080 ppm (0.03; 0.05–0.14). The observed susceptibility values in cortical 
Figure 3.  Comparison of DWI, SWI, MIP and QSM in 2 different patients for cortical vein identification. 
(a–d) represent one patient while (e–h) represent another patient. Image (a) and (e) demonstrate the ischemic 
core of the ischemic hemisphere, which is hyperintense on DWI. A selection of cortical veins (red arrows) is 
demonstrated on SWI (b and f), MIP (c and g) and QSM (d and h) in control and ischemic hemisphere. Note 
that the visibility of cortical veins within the infarction core is reduced. Cortical veins within the ipsilateral non-
ischemic MCA territory and contralateral MCA territory seem to have comparable intensity.
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Table 1.  Patient clinical characteristics. Clinical characteristics of all 23 patients. Numbers (n) and percentage 




Age, median (IQR) 72 (45–90)
Female, n (%) 10 (43%)
Risk factors, n (%)




Coronary heart disease 2 (9%)
Atrial fibrillation 10 (43%)
Persistent foramen ovale 0 (0%)
Stroke etiology, n (%)
Large-vessel disease 1 (4%)
Cardioembolic 12 (52%)
Small-artery disease 0 (0%)
Other causes 2 (9%)
Undetermined 8 (35%)
Table 2.  Treatment and outcome characteristics. Treatment and Outcome characteristics. In order to 
assess the reestablished blood flow, the ipsilateral and contralateral MCA-M1 were examined using duplex 
sonography. In 2/23 cases duplex sonography examination was not possible. Median, interquartile range (IQR), 
minimum and maximum are shown.
Duplex parameters
(n = 21)
Flow MCA-M1 [cm/s], median (IQR, min/max)
Ipsilateral systolic 97 (49, 47–178)
Contralateral systolic 94 (42, 60–146)
Ipsilateral diastolic 39 (20, 22–62)
Contralateral diastolic 37 (12, 20–61)
Treatment parameters
(n = 23)
Clinical scores, median (IQR, min/max)
NIHSS on admission 13 (6, 3–19)
NIHSS after 24 h 5 (7.5, 0–22)
NIHSS improvement 4 (9.5, − 9–14)
mRS after 3 months 2 (2.5, 0–6)
Onset-to-needle time [min], median (IQR, min/max) 150 (111, 40–390)
Table 3.  QSM susceptibility and infarct size. QSM susceptibility values of cortical veins within the stroke 
area, the ipsilateral infarct surrounding MCA territory and the contralateral MCA territory. Additionally, we 




QSM susceptibility cortical vein values, median (IQR, min/max)
Stroke area 0.050 (0.02, 0.03–0.08)
Ipsilateral infarct surrounding area 0.085 (0.04, 0.05–0.12)
Contralateral MCA territory 0.080 (0.03, 0.05–0.14)
Infarct size  [cm3], median (IQR, min/max) 33.5 (71.5, 1.1–250.8)
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veins of the infarct area were 41% lower compared to the ipsilateral non-ischemic MCA territory and 38% lower 
compared to the contralateral MCA territory (p-value < 0.001). There was no significant differences in magnetic 
susceptibility between veins in the ipsilateral non-infarcted MCA territory and contralateral MCA territory.
Cortical vein susceptibilities within the infarct core did not correlate with early infarct volume (Pearson’s cor-
relation coefficient of 0.276, p-value = 0.202) or severity of mean initial ADC decrease within the infarct (Pearson’s 
correlation coefficient of − 0.151, p-value = 0.493). We further analyzed a potential relationship between venous 
susceptibilities within the infarct and the clinical parameters initial stroke severity on NIHSS or 3–5 months 
functional disability on mRS, and found no such correlation (for NIHSS on admission: Pearson’s correlation coef-
ficient of − 0.161, p-value = 0.464; for 3–5 month mRS: Pearson’s correlation coefficient of 0.253, p-value = 0.253).
Discussion
In patients successfully recanalized by thrombectomy after stroke due to occlusion of the MCA-M1/M2 segment, 
we found distinct patterns of cortical vein susceptibility in the ipsilateral MCA territory using QSM. While lower 
venous susceptibility values were found within the infarct core, susceptibilites in the ipsilateral non-infarcted 
MCA territory were similar to the venous susceptibilities within the unaffected contralateral MCA territory.
QSM has been proven useful to asses vascular oxygenation in the  brain14. Several papers have reported 
prominent veins (APCV) on susceptibility maps in patients with hyperacute and acute stroke, i.e. veins that 
were more visble and had larger diameter and length than those on the contralateral hemisphere or in healthy 
 controls18,21. The presence of APCV has been hypothesized to be related to increased deoxyhemoglobin resulting 
from increased  OEF13,35. A previous study found APCV in the infarct territories of hyperacute stroke patients 
(mean time from symptom onset to MRI acquisition 15 ± 4 h)22. The authors concluded that these prominent 
vessels could reflect a decrease of oxygen saturation in APCV which was estimated to be 16–44%. Luo et al. 
demonstrated that patients with APCVs have a tendency of deterioration of the neurological deficit while patients 
with no apparent APCVs tend to  improve18. A study by Kim et al. has shown that APCV are not only observed 
in the cortex areas but also in deep thalamostriatal areas and that susceptibility values showed a strong inverse 
correlation with initial  NIHSS36. It is expected that APCV disappear upon restoration of tissue perfusion, but 
this has not been investigated with QSM systematically.
We selected patients with verified recanalization of the MCA territory by catheter angiography (TICI 2b 
or TICI 3 score according to the TICI reperfusion grade) as well as duplex sonography measurements, which 
showed similar flow in the ipsi- and contralateral MCA-M1 segment. APCVs were clearly not detected in corti-
cal regions. We found two vessel types within the affected vascular territory: veins with decreased QSM signal 
in the infarct core and veins with normal susceptibility values in the non-infarcted MCA territories. While we 
have not evaluated the presence of APCVs in the acute stage, one possibility is that the absence of prominent 
vessels represents a normalization of the OEF in the non-ischemic territories after reperfusion and oxygenation 
is  restored35. Further studies are needed to investigate oxygenation status after acute ischemic stroke. Our results 
are in contrast to two recent preclinical QSM studies that detected increased QSM susceptibility values in veins 
within the infarct or penumbral areas after  reperfusion16,19. A study observed increased venous susceptibilities 
after induction of a transient occlusion in the middle cerebral artery in rats. The increased venous susceptibili-
ties were related to lower venous oxygen  saturation16. A study in mice found higher susceptibility values in the 
ischemic hemisphere, particularly in the infarct border zone, after transient middle cerebral artery  occlusion19. 
Figure 4.  Comparison of the susceptibility values of the cortical veins within the stroke area, the ipsilateral 
non-ischemic MCA territory and the contralateral MCA territory. Areas that significantly (p < 0.05) differ from 
other areas regarding their susceptibility value are indicated (*)°indicates outliers.
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Immunohistochemistry revealed the presence of compressed capillaries and dilated larger vessels. This suggests 
that in animal models of transient cerebral ischemia, recanalization of the major feeding artery does not lead to 
a complete reperfusion of cerebral tissue and the appearance of prominent vessels with an increased OEF may 
serve compensatory purposes. Such no-reflow or reperfusion failure has been described in both animal models 
and stroke patients, representing a serious obstacle to  recovery37.
DWI is an established imaging method to evaluate early infarct size and predict imaging as well as clinical 
 outcome38. We did not find a correlation of susceptibility values to stroke severity, functional disability, or final 
infarct size in our patients. Therefore, we did not find evidence that susceptibility measured after recanalization 
in patients with stroke due to MCA-M1/M2 indicates severity of tissue damage.
The flow-compensated T2*-weighted data utilized for QSM were acquired in the clinical setting with the SWI 
acquisition scheme established in-house, providing a familiar view to the radiologists. Thus, venous susceptibility 
analysis relied on a single echo acquired with TE = 20 and a long echo readout and came without an additional 
measurement, as only the post-processing needed adjustment. Although multi-echo gradient-echo imaging has 
been suggested for QSM in particular for studying iron depositions, their application for studying venous vessels 
is not recommened, as 3D flow-compensation is typically not provided for all echoes. Incomplete flow compen-
sation leads to flow-related phase contributions that are not due to magnetic  susceptibility39–42. Consequently, 
non-local artifacts occurring adjacent to vessels with high blod flow might occur on the susceptibility  map40.
Limitations. As a limitation of our study, MRI measurements were done at a single time point, so that tran-
sient shifts in QSM signal earlier or later may have been missed. Furthermore, pathophysiological differences 
between stroke due to MCA occlusion in rodents and MCA stroke in human patients such as stroke duration/
severity, collateral flow, or medication (anticoagulation, blood pressure medication) might play a role, causing a 
different dynamic of tissue  oxygenation35. While venous ROIs were carefully identified based on MIP and SWI 
maps, the resulting venous susceptibility values are prone to partial volume effects, which is indicated by the 
low QSM values in small veins in our study. We calculated the venous susceptibility from the 10% highest signal 
within the vein mask to overcome the problem of partial volume effects.
Another limitation of our study is the lack of information about reperfusion status on capillary level. While 
results of catheter angiography and duplex sonography conducted in our patient cohort indicates full reperfusion, 
this is not comparable to an in-depth (e.g., immunohistochemical) confirmation about reperfusion on a capil-
lary level. Since no perfusion imaging was performed at the time of QSM imaging, there was no assessment of 
tissue perfusion available to confirm reperfusion status. However, vessels in the peri-infarct region were mainly 
located in the area of hypoperfusion on the initial (pre-thrombectomy) perfusion images.
While we chose a homogenous patient cohort (all recanalized MCA-M1/M2 occlusions) to draw more valid 
conclusions according to the affected vascular territory and recanalization the sample size is small. Another 
limitation is that masks for individual cortical veins were drawn semi-automatically and some vessels might not 
have been identified because of edema compressing them. However, the semi-automatic approach allowed to 
carefully inspect and correct blood vessel segmentations. Finally, we did not compare our results to healthy con-
trols, but used the contralateral hemisphere for comparison instead, which may have altered susceptibility as well.
Conclusion
In conclusion, we found distinct patterns of cortical vein susceptibility after recanalization of acute ischemic 
stroke and our findings indicate that the susceptibility signal is highly dynamic in stroke. As QSM reflects tissue 
oxygenation in stroke patients with recanalized MCA-M1/M2 occlusion, it has potential to aid in understanding 
the complex processes that follow transient cerebral ischemia.
Further studies in larger patient cohorts on QSM vein susceptibilities may derive differences in stroke tissue 
prognosis with clinical implications for stroke patients.
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